Homevale strives to maximize quality of care while serving patients and families.
Homevale Partners acquires, grows, and improves care quality and operations at home-based care businesses across private duty, infusion and injection nursing, and hospice.
Past success includes investing in, growing, and selling both the largest home healthcare company in the nation LHC Group, and Medalogix, one of the largest providers of clinical decision support software.
Homevale's founder and partners have invested in and operated businesses across the home-based care continuum.
A Homevale partner was a significant investor in LHC Group, helping drive its growth into the largest home health and hospice operator in the United States. Acquired by UnitedHealth Group/Optum for $5.4 billion in 2023.
A Homevale partner acquired and merged this AI-powered clinical decision support platform, then served as a senior executive helping scale it to serve approximately one-third of all Medicare home health and hospice recipients. Acquired by Berkshire Partners in 2025 for an undisclosed sum.
We acquire and grow home care businesses across private duty, in-home infusion and injection nursing, and hospice.
In-home personal care and support services.
Skilled in-home IV therapy and injection nursing.
Compassionate end-of-life care focused on comfort.